Sartan medicines: companies to review manufacturing processes to avoid presence of nitrosamine impurities

Our website uses cookies!

We would like to inform you that we use cookies on our website to enhance the user experience, to analyze our content and website traffic, and for marketing purposes.

By continuing to browse our website and clicking on the I accept button, you consent to the use of cookies.

You will find a detailed description of the settings in the Cookie Information.